vs
ASSOCIATED BANC-CORP（ASB）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是ASSOCIATED BANC-CORP的1.3倍（$493.8M vs $383.0M），ASSOCIATED BANC-CORP净利率更高（31.2% vs 6.8%，领先24.4%），过去两年ASSOCIATED BANC-CORP的营收复合增速更高（9.1% vs -0.1%）
联合银行集团（Associated Banc-Corp）是美国区域性银行控股公司，总部位于威斯康星州格林贝，深耕美国中西部地区，主营零售银行、商业银行、商业地产贷款、私人银行及特色金融服务，在威斯康星州、伊利诺伊州、明尼苏达州设有220多个营业网点，覆盖100多个社区，还在印第安纳、密歇根等多州设有贷款办事处。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
ASB vs MD — 直观对比
营收规模更大
MD
是对方的1.3倍
$383.0M
净利率更高
ASB
高出24.4%
6.8%
两年增速更快
ASB
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $383.0M | $493.8M |
| 净利润 | $119.6M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | — | 9.9% |
| 净利率 | 31.2% | 6.8% |
| 营收同比 | — | -1.7% |
| 净利润同比 | 566.6% | 10.5% |
| 每股收益（稀释后） | $0.70 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASBMD
| Q1 26 | $383.0M | — | ||
| Q4 25 | $310.0M | $493.8M | ||
| Q3 25 | $305.2M | $492.9M | ||
| Q2 25 | $300.0M | $468.8M | ||
| Q1 25 | $285.9M | $458.4M | ||
| Q4 24 | $270.3M | $502.4M | ||
| Q3 24 | $329.7M | $511.2M | ||
| Q2 24 | $321.8M | $504.3M |
净利润ASBMD
| Q1 26 | $119.6M | — | ||
| Q4 25 | $137.1M | $33.7M | ||
| Q3 25 | $124.7M | $71.7M | ||
| Q2 25 | $111.2M | $39.3M | ||
| Q1 25 | $101.7M | $20.7M | ||
| Q4 24 | $-161.6M | $30.5M | ||
| Q3 24 | $88.0M | $19.4M | ||
| Q2 24 | $115.6M | $-153.0M |
营业利润率ASBMD
| Q1 26 | — | — | ||
| Q4 25 | 52.6% | 9.9% | ||
| Q3 25 | 50.5% | 13.8% | ||
| Q2 25 | 46.5% | 12.8% | ||
| Q1 25 | 42.3% | 7.0% | ||
| Q4 24 | -65.8% | 7.8% | ||
| Q3 24 | 32.8% | 6.6% | ||
| Q2 24 | 32.0% | -31.3% |
净利率ASBMD
| Q1 26 | 31.2% | — | ||
| Q4 25 | 44.2% | 6.8% | ||
| Q3 25 | 40.9% | 14.5% | ||
| Q2 25 | 37.1% | 8.4% | ||
| Q1 25 | 35.6% | 4.5% | ||
| Q4 24 | -59.8% | 6.1% | ||
| Q3 24 | 26.7% | 3.8% | ||
| Q2 24 | 35.9% | -30.3% |
每股收益（稀释后）ASBMD
| Q1 26 | $0.70 | — | ||
| Q4 25 | $0.80 | $0.40 | ||
| Q3 25 | $0.73 | $0.84 | ||
| Q2 25 | $0.65 | $0.46 | ||
| Q1 25 | $0.59 | $0.24 | ||
| Q4 24 | $-1.10 | $0.37 | ||
| Q3 24 | $0.56 | $0.23 | ||
| Q2 24 | $0.74 | $-1.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $375.2M |
| 总债务越低越好 | — | $570.5M |
| 股东权益账面价值 | $5.0B | $865.9M |
| 总资产 | $45.6B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资ASBMD
| Q1 26 | — | — | ||
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
总债务ASBMD
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $570.5M | ||
| Q3 25 | $594.1M | $577.2M | ||
| Q2 25 | $593.5M | $583.9M | ||
| Q1 25 | $591.4M | $590.5M | ||
| Q4 24 | $1.4B | $597.1M | ||
| Q3 24 | $844.3M | — | ||
| Q2 24 | $536.1M | — |
股东权益ASBMD
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $865.9M | ||
| Q3 25 | $4.9B | $890.7M | ||
| Q2 25 | $4.8B | $833.8M | ||
| Q1 25 | $4.7B | $789.2M | ||
| Q4 24 | $4.6B | $764.9M | ||
| Q3 24 | $4.4B | $732.5M | ||
| Q2 24 | $4.2B | $706.5M |
总资产ASBMD
| Q1 26 | $45.6B | — | ||
| Q4 25 | $45.2B | $2.2B | ||
| Q3 25 | $44.5B | $2.2B | ||
| Q2 25 | $44.0B | $2.1B | ||
| Q1 25 | $43.3B | $2.0B | ||
| Q4 24 | $43.0B | $2.2B | ||
| Q3 24 | $42.2B | $2.1B | ||
| Q2 24 | $41.6B | $2.0B |
负债/权益比ASBMD
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | 0.66× | ||
| Q3 25 | 0.12× | 0.65× | ||
| Q2 25 | 0.12× | 0.70× | ||
| Q1 25 | 0.13× | 0.75× | ||
| Q4 24 | 0.31× | 0.78× | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASBMD
| Q1 26 | — | — | ||
| Q4 25 | $218.1M | $114.1M | ||
| Q3 25 | $158.0M | $137.3M | ||
| Q2 25 | $141.5M | $137.2M | ||
| Q1 25 | $98.2M | $-117.5M | ||
| Q4 24 | $207.1M | $133.0M | ||
| Q3 24 | $105.1M | $91.8M | ||
| Q2 24 | $113.5M | $107.0M |
现金转化率ASBMD
| Q1 26 | — | — | ||
| Q4 25 | 1.59× | 3.39× | ||
| Q3 25 | 1.27× | 1.91× | ||
| Q2 25 | 1.27× | 3.49× | ||
| Q1 25 | 0.97× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 1.19× | 4.72× | ||
| Q2 24 | 0.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASB
| Net Interest Income | $307.2M | 80% |
| Noninterest Income | $75.9M | 20% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
